Abstract Details

Title The Effects of Sublingual Apomorphine (APL-130277) by Disease Severity on the Acute Management of OFF Episodes in Parkinson’s Disease

Topic Movement Disorders

Presentation(s) (-)

Poster/Presentation
Number 336

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Holly A. Shill, MD, FAAN (Barrow Neurology Clinics) PRESENTER	Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage Biogen. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for KeifeRx. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis Precision Medicine. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fasikl Inc. Dr. Shill has received personal compensation in the range of $0-$499 for serving as a Consultant for Boston Scientific. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America.
Eric J. Pappert, MD (Neurology Associates)	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file

��ɫ��